Company Description
Xtacy Therapeutics Corp. (GWSFF) is a prospect generator assisting high growth companies in the wellness consumer products market. The company recently settled debt by issuing 2,361,500 common shares to creditors, reducing liabilities and improving financial position. With a focus on global wellness, psychedelics, mycology, hemp, and CBD, Xtacy provides financial, operational, and management support to healthcare-related target companies. The securities issued in the debt settlement are subject to a statutory hold period of four months plus a day from the date of issuance. Visit the website for more information.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Xtacy Therapeutics.